Lenalidomide and Chronic Lymphocytic Leukemia

dc.contributor.author	González Rodríguez, Ana Pilar
dc.contributor.author	Payer, Ángel R.
dc.contributor.author	Acebes Huerta, Andrea
dc.contributor.author	Huergo Zapico, Leticia
dc.contributor.author	Villa Álvarez, Mónica
dc.contributor.author	González García, María Esther
dc.contributor.author	González Rodríguez, Segundo
dc.date.accessioned	2013-11-27T11:30:15Z
dc.date.available	2013-11-27T11:30:15Z
dc.date.issued	2013
dc.identifier.citation	Biomed Research International, 932010(2013); doi:10.1155/2013/932010
dc.identifier.issn	2314-6133
dc.identifier.uri	http://hdl.handle.net/10651/19949
dc.description.sponsorship	This work was supported by the Spanish grants of Fondo de Investigaciones Sanitarias (Institute Carlos III) PI12/01280.
dc.format.extent	932010
dc.language.iso	eng
dc.relation.ispartof	Biomed Research International
dc.rights	© Ana Pilar González-Rodríguez et al.
dc.rights	CC Reconocimiento - No comercial - Sin obras derivadas 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	WOK
dc.title	Lenalidomide and Chronic Lymphocytic Leukemia	eng
dc.type	journal article
dc.identifier.local	20131161
dc.identifier.doi	10.1155/2013/932010
dc.relation.projectID	FIS-PI12/01280
dc.relation.publisherversion	http://dx.doi.org/10.1155/2013/932010
dc.rights.accessRights	open access

Este ítem está sujeto a una licencia Creative Commons